We synthesize the world’s biomedical knowledge.
Natural language is at the heart of how we learn, associate and communicate concepts and ideas in healthcare. However, our capacity to read and process this wealth of information cannot keep up with the explosion of biomedical literature. What if we could synthesize all the world’s biomedical knowledge to augment our ability to generate insights and improve the way we make decisions in healthcare?
Healthcare faces a seemingly unsurmountable task of data silo-ism. Information exists as unstructured and structured text in the form of literature, omics data, real world evidence (RWE), electronic health records (EHR) and other bio-signals. Separately, they offer limited utility. However, we believe healthcare can be reimagined by triangulating concordant signals from all those data siloes. What if we could break the barriers of healthcare data silos to power novel discoveries? nference has the solution.
The nference team, comprised of successful serial tech entrepreneurs and leading data, research and clinical scientists trained at Massachusetts Institute of Technology (MIT) and Harvard Medical School, works closely with pharmaceutical partners to solve some of today’s biggest challenges in drug discovery and clinical research. At the heart of these collaborations, our AI software platform - nferX - plays a central role in augmenting the scientists’ abilities to generate holistic data-driven and unbiased hypotheses in a rapid manner. nferX uses state-of-the-art neural networks (shallow and deep learning models) for real-time, automated extraction of knowledge from scientific, clinical, regulatory and commercial datasets.
As the first significant move toward AI-powered drug development, nference and the Mayo Clinic established the Qrativ joint venture in 2017 to purpose clinically-tested therapeutic programs for more optimal disease processes with significant unmet need. nference will continue to selectively establish additional partnerships with eminent healthcare organizations and pharmaceutical companies. These organizations have complementary expertise and rich troves of proprietary longitudinal data sets that amplify the impact of the nference AI platform in drugs, diagnostics, and digital solutions.
We are located at the heart of Kendall Square in Cambridge , MA—the world’s largest biotech hub.
101 Main Street, 15th floor
Cambridge, MA 02142